Edward Brent Perkins

The Zinc Finger Repressor, ZBP-89, Binds to the Silencer Element of the Human Vimentin Gene and Complexes with the Transcriptional Activator, Sp1

Elżbieta Wieczorek, Zhili Lin, Edward Brent Perkins et al. · Journal of Biological Chemistry · 2000 · 68 citations · Full text

Phase I Trial of Bortezomib (PS-341; NSC 681239) and Alvocidib (Flavopiridol; NSC 649890) in Patients with Recurrent or Refractory B-Cell Neoplasms

Beata Holkova, Edward Brent Perkins, Viswanathan Ramakrishnan et al. · Clinical Cancer Research · 2011 · 48 citations · Full text

A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell Lymphoma

Victor Yazbeck, Danielle Shafer, Edward Brent Perkins et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 40 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Phase Ii Trial +7

A Phase I Trial of Vorinostat and Alvocidib in Patients with Relapsed, Refractory, or Poor Prognosis Acute Leukemia, or Refractory Anemia with Excess Blasts-2

Beata Holkova, Jeffrey G. Supko, Matthew M. Ames et al. · Clinical Cancer Research · 2013 · 34 citations · Full text

A GC-box is required for expression of the human vimentin gene

Elena S. Izmailova, Elżbieta Wieczorek, Edward Brent Perkins et al. · Gene · 1999 · 28 citations

Protein Expression, Genetics, Pathogenesis +5